A statement released earlier today by Goldman Sachs about Steris (NYSE:STE) bumps the target price to $71.00
- Updated: November 30, 2016
Goldman Sachs bumped up the target of Steris (NYSE:STE) to $71.00 stating a potential upside of 0.08%.
Boasting a price of $65.90, Steris (NYSE:STE) traded 0.52% higher on the day. With the last stock price close down -3.14% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the date range. Steris has recorded a 50-day average of $67.37 and a two hundred day average of $69.42. Volume of trade was down over the average, with 8,263 shares of STE changing hands under the typical 502,394
With a total market value of $0, Steris has price-earnings ratio of 33.94 with a one year low of $61.38 and a one year high of $78.77 .
A total of 6 equity analysts have released a ratings update on STE. Two equity analysts rating the company a strong buy, three equity analysts rating the company a buy, two equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $86.33.
Brief Synopsis About Steris (NYSE:STE)
STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. Its Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. This segment also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; cleaning chemistries and sterility assurance products; and hard surface disinfectants, skin care, and hand hygiene solutions. In addition, it offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The companyÂ’s Healthcare Specialty Services segment offers instrument and endoscope repair and maintenance solutions; on site and off site reprocessing surgical instruments, as well as custom process consulting; and outsourced linen rental, reprocessing, and managed supply chain solutions. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The companyÂ’s Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 59 facilities. STERIS plc was founded in 1985 and is headquartered in Leicester, the United Kingdom.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.